Makiko Hoshiya
Overview
Explore the profile of Makiko Hoshiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
82
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoshiya M, Christian B, Cromie W, Kim H, Zhan Y, MacLaughlin D, et al.
Birth Defects Res A Clin Mol Teratol
. 2004 Jan;
67(10):868-74.
PMID: 14745940
Background: Persistent Mullerian duct syndrome (PMDS) is a rare form of male pseudohermaphroditism that is characterized by the persistence of Mullerian derivatives in otherwise normally virilized males. Mutations of the...
2.
Hoshiya Y, Gupta V, Segev D, Hoshiya M, Carey J, Sasur L, et al.
Mol Cell Endocrinol
. 2003 Dec;
211(1-2):43-9.
PMID: 14656475
The MIS type II receptor is expressed at high levels in the Mullerian duct and in Sertoli cells and granulosa cells of the embryonic and adult gonads. The presence of...
3.
Hida M, Fujita H, Ishikura K, Omori S, Hoshiya M, Awazu M
J Cell Physiol
. 2003 Jun;
196(2):293-300.
PMID: 12811822
Eicosapentaenoic acid (EPA), an omega-3 polyunsaturated fatty acid derived from fish oil, is efficacious in glomerular diseases where mesangial proliferation is a key event. We examined the mechanisms of action...
4.
Segev D, Hoshiya Y, Hoshiya M, Tran T, Carey J, Stephen A, et al.
Proc Natl Acad Sci U S A
. 2002 Jan;
99(1):239-44.
PMID: 11773638
Mullerian-inhibiting substance (MIS) is a member of the transforming growth factor beta superfamily, a class of molecules that regulates growth, differentiation, and apoptosis in many cells. MIS type II receptor...